| 1 | [SID17401924] | Active | CC50 | 6.76e-06 | Cytotoxicity counterscreen assay for transcriptional activators of heat shock protein 70 (Hsp70) [AID1259, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 17401924 | | CID | 11957207 | | Outcome | Active | | CC50 | 6.76e-06 [uM] | | BioAssay | Cytotoxicity counterscreen assay for transcriptional activators of heat shock protein 70 (Hsp70) | | AID | 1259 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID17401924] | Active | IC50 | 0.691 | Fluorescence dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4) [AID1692, Type: confirmatory] | Sphingosine-1-phosphate receptor 4 [Homo sapiens] [gi:15929025] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 17401924 | | CID | 11957207 | | Outcome | Active | | IC50 | 0.691 [uM] | | BioAssay | Fluorescence dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4) | | AID | 1692 | | BioAssay type | confirmatory | | Target | Sphingosine-1-phosphate receptor 4 [Homo sapiens] [gi:15929025] | | PubMed | | | Data Table |  |
|
| 3 | [SID17401924] | Active | IC50 | 0.691 | Fluorescence dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4) [AID1692, Type: confirmatory] | Sphingosine-1-phosphate receptor 4 [Homo sapiens] [gi:15929025] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 17401924 | | CID | 11957207 | | Outcome | Active | | IC50 | 0.691 [uM] | | BioAssay | Fluorescence dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4) | | AID | 1692 | | BioAssay type | confirmatory | | Target | Sphingosine-1-phosphate receptor 4 [Homo sapiens] [gi:15929025] | | PubMed | | | Data Table |  |
|
| 4 | [SID17401924] | Active | EC50 | 2.065 | High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor - Dose Response [AID1047, Type: confirmatory] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 17401924 | | CID | 11957207 | | Outcome | Active | | EC50 | 2.065 [uM] | | BioAssay | High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor - Dose Response | | AID | 1047 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID17401924] | Active | EC50 | 2.147 | High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression - Dose Response [AID1045, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 17401924 | | CID | 11957207 | | Outcome | Active | | EC50 | 2.147 [uM] | | BioAssay | High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression - Dose Response | | AID | 1045 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID87349637] | Active | Potency | 2.2387 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | Potency | 2.2387 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID87349637] | Active | Potency | 2.5119 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | Potency | 2.5119 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 8 | [SID87349637] | Active | Potency | 2.5119 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | Potency | 2.5119 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 9 | [SID87349637] | Active | Potency | 2.5119 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | Potency | 2.5119 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 10 | [SID87349637] | Active | Potency | 2.8184 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | Potency | 2.8184 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 11 | [SID87349637] | Active | Potency | 2.8184 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | Potency | 2.8184 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 12 | [SID87349637] | Active | Potency | 2.8184 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | Potency | 2.8184 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 13 | [SID87349637] | Active | Potency | 2.8184 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | Potency | 2.8184 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID87349637] | Active | Potency | 3.5481 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID87349637] | Active | Potency | 3.5481 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 16 | [SID87349637] | Active | Potency | 3.5481 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 17 | [SID87349637] | Active | Potency | 3.5481 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 18 | [SID87349637] | Active | Potency | 3.5481 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 19 | [SID17401924] | Active | IC50 | 3.741 | Fluorescence-based counterscreen assay for S1P4 antagonists: Cell-based dose response high throughput screening assay to identify antagonists of the Sphingosine 1-Phosphate Receptor 1 (S1P1) [AID1821, Type: confirmatory] | S1PR1 gene product [Homo sapiens] [gi:13027636] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 17401924 | | CID | 11957207 | | Outcome | Active | | IC50 | 3.741 [uM] | | BioAssay | Fluorescence-based counterscreen assay for S1P4 antagonists: Cell-based dose response high throughput screening assay to identify antagonists of the Sphingosine 1-Phosphate Receptor 1 (S1P1) | | AID | 1821 | | BioAssay type | confirmatory | | Target | S1PR1 gene product [Homo sapiens] [gi:13027636] | | PubMed | | | Data Table |  |
|
| 20 | [SID17401924] | Active | IC50 | 3.741 | Fluorescence-based counterscreen assay for S1P4 antagonists: Cell-based dose response high throughput screening assay to identify antagonists of the Sphingosine 1-Phosphate Receptor 1 (S1P1) [AID1821, Type: confirmatory] | S1PR1 gene product [Homo sapiens] [gi:13027636] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 17401924 | | CID | 11957207 | | Outcome | Active | | IC50 | 3.741 [uM] | | BioAssay | Fluorescence-based counterscreen assay for S1P4 antagonists: Cell-based dose response high throughput screening assay to identify antagonists of the Sphingosine 1-Phosphate Receptor 1 (S1P1) | | AID | 1821 | | BioAssay type | confirmatory | | Target | S1PR1 gene product [Homo sapiens] [gi:13027636] | | PubMed | | | Data Table |  |
|
| 21 | [SID87349637] | Active | Potency | 3.9811 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | Potency | 3.9811 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 22 | [SID87349637] | Active | Potency | 3.9811 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | Potency | 3.9811 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 23 | [SID17401924] | Active | AC50 | 3.989 | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis [AID449756, Type: confirmatory] | |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 17401924 | | CID | 11957207 | | Outcome | Active | | AC50 | 3.989 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis | | AID | 449756 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 24 | [SID17401924] | Active | AC50 | 4.33 | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick [AID463229, Type: confirmatory] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 17401924 | | CID | 11957207 | | Outcome | Active | | AC50 | 4.33 [uM] | | BioAssay | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick | | AID | 463229 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID87349637] | Active | Potency | 5.0119 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | Potency | 5.0119 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 26 | [SID87349637] | Active | Potency | 5.0119 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | Potency | 5.0119 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 27 | [SID87349637] | Active | Potency | 5.0119 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | Potency | 5.0119 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 28 | [SID17401924] | Active | Potency | 5.0119 | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 17401924 | | CID | 11957207 | | Outcome | Active | | Potency | 5.0119 [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 29 | [SID17401924] | Active | Potency | 5.1735 | qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells [AID2685, Type: confirmatory] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 17401924 | | CID | 11957207 | | Outcome | Active | | Potency | 5.1735 [uM] | | BioAssay | qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells | | AID | 2685 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID17401924] | Active | Potency | 5.2213 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 17401924 | | CID | 11957207 | | Outcome | Active | | Potency | 5.2213 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID87349637] | Active | IC50 | 5.29 | Discovery of Small Molecule Probes for H1N1 NS1a - H1N1 (KY136) Influenza Antiviral Screen [AID540257, Type: confirmatory] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | IC50 | 5.29 [uM] | | BioAssay | Discovery of Small Molecule Probes for H1N1 NS1a - H1N1 (KY136) Influenza Antiviral Screen | | AID | 540257 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID17401924] | Active | Potency | 5.6234 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 17401924 | | CID | 11957207 | | Outcome | Active | | Potency | 5.6234 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID87349637] | Active | Potency | 6.3096 | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. [AID624297, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. | | AID | 624297 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 34 | [SID87349637] | Active | Potency | 7.0795 | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. [AID624296, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. | | AID | 624296 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 35 | [SID17401924] | Active | Potency | 7.0795 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 17401924 | | CID | 11957207 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 36 | [SID17401924] | Active | EC50 | 7.59 | Dose Response confirmation of Image-Based HTS for Selective Agonists for NTR1 [AID504549, Type: confirmatory] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 17401924 | | CID | 11957207 | | Outcome | Active | | EC50 | 7.59 [uM] | | BioAssay | Dose Response confirmation of Image-Based HTS for Selective Agonists for NTR1 | | AID | 504549 | | BioAssay type | confirmatory | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|
| 37 | [SID17401924] | Active | EC50 | 7.59 | Dose Response confirmation of Image-Based HTS for Selective Agonists for NTR1 [AID504549, Type: confirmatory] | NTSR1 gene product [Homo sapiens] [gi:110611243] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 17401924 | | CID | 11957207 | | Outcome | Active | | EC50 | 7.59 [uM] | | BioAssay | Dose Response confirmation of Image-Based HTS for Selective Agonists for NTR1 | | AID | 504549 | | BioAssay type | confirmatory | | Target | NTSR1 gene product [Homo sapiens] [gi:110611243] | | PubMed | | | Data Table |  |
|
| 38 | [SID87349637] | Active | Potency | 7.9433 | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen [AID624418, Type: confirmatory] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen | | AID | 624418 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID87349637] | Active | Potency | 7.9433 | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 40 | [SID87349637] | Active | Potency | 8.1995 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay [AID602202, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | Potency | 8.1995 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay | | AID | 602202 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 41 | [SID87349637] | Active | Potency | 8.1995 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay [AID602202, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | Potency | 8.1995 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay | | AID | 602202 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 42 | [SID87349637] | Active | Potency | 8.1995 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay [AID602202, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | Potency | 8.1995 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay | | AID | 602202 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 43 | [SID87349637] | Active | Potency | 8.1995 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay [AID602202, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | Potency | 8.1995 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay | | AID | 602202 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 44 | [SID17401924] | Active | Potency | 10 | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity [AID2546, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 17401924 | | CID | 11957207 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2546 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 45 | [SID87349637] | Active | Potency | 10.6213 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Cytotoxicity Assay [AID602204, Type: confirmatory] | |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 87349637 | | CID | 11957207 | | Outcome | Active | | Potency | 10.6213 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Cytotoxicity Assay | | AID | 602204 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 46 | [SID17401924] | Active | IC50 | 10.8 | Luminescent assay for HTS discovery of chemical inhibitors of placental alkaline phosphatase [AID690, Type: confirmatory] | alkaline phosphatase, placental-like preproprotein [Homo sapiens] [gi:157266296] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 17401924 | | CID | 11957207 | | Outcome | Active | | IC50 | 10.8 [uM] | | BioAssay | Luminescent assay for HTS discovery of chemical inhibitors of placental alkaline phosphatase | | AID | 690 | | BioAssay type | confirmatory | | Target | alkaline phosphatase, placental-like preproprotein [Homo sapiens] [gi:157266296] | | PubMed | | | Data Table |  |
|
| 47 | [SID17401924] | Active | IC50 | 10.8 | Luminescent assay for HTS discovery of chemical inhibitors of placental alkaline phosphatase [AID690, Type: confirmatory] | alkaline phosphatase, placental-like preproprotein [Homo sapiens] [gi:157266296] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 17401924 | | CID | 11957207 | | Outcome | Active | | IC50 | 10.8 [uM] | | BioAssay | Luminescent assay for HTS discovery of chemical inhibitors of placental alkaline phosphatase | | AID | 690 | | BioAssay type | confirmatory | | Target | alkaline phosphatase, placental-like preproprotein [Homo sapiens] [gi:157266296] | | PubMed | | | Data Table |  |
|
| 48 | [SID17401924] | Active | AC50 | 12.39 | Luminescence Cell-Based Secondary Screen to Identify Inhibitors of A1(alternate construct) [AID449757, Type: confirmatory] | Bcl-2-like protein 11 [gi:18202042] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 17401924 | | CID | 11957207 | | Outcome | Active | | AC50 | 12.39 [uM] | | BioAssay | Luminescence Cell-Based Secondary Screen to Identify Inhibitors of A1(alternate construct) | | AID | 449757 | | BioAssay type | confirmatory | | Target | Bcl-2-like protein 11 [gi:18202042] | | PubMed | | | Data Table |  |
|
| 49 | [SID17401924] | Active | AC50 | 12.39 | Luminescence Cell-Based Secondary Screen to Identify Inhibitors of A1(alternate construct) [AID449757, Type: confirmatory] | Bcl-2-like protein 11 [gi:18202042] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 17401924 | | CID | 11957207 | | Outcome | Active | | AC50 | 12.39 [uM] | | BioAssay | Luminescence Cell-Based Secondary Screen to Identify Inhibitors of A1(alternate construct) | | AID | 449757 | | BioAssay type | confirmatory | | Target | Bcl-2-like protein 11 [gi:18202042] | | PubMed | | | Data Table |  |
|
| 50 | [SID17401924] | Active | AC50 | 12.39 | Luminescence Cell-Based Secondary Screen to Identify Inhibitors of A1(alternate construct) [AID449757, Type: confirmatory] | Bcl-2-like protein 11 [gi:18202042] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 17401924 | | CID | 11957207 | | Outcome | Active | | AC50 | 12.39 [uM] | | BioAssay | Luminescence Cell-Based Secondary Screen to Identify Inhibitors of A1(alternate construct) | | AID | 449757 | | BioAssay type | confirmatory | | Target | Bcl-2-like protein 11 [gi:18202042] | | PubMed | | | Data Table |  |
|